In 2023, the sold production of hormones, prostaglandins, thromboxanes, and leukotrienes in Germany was valued at 170.92 million Euros. From 2024 to 2028, the forecast indicates a steady growth with a year-on-year growth rate of approximately 0.43% to 0.49%. The compound annual growth rate (CAGR) for the period is roughly 0.50%. This gradual increase suggests stability and sustained demand in the market.

Future trends to watch for:

Technological advancements in biotechnology and pharmaceuticals may drive faster growth.
Regulatory changes impacting production processes.
Rising demand for personalized medicine and biologics could influence production trends.